Nizamudin M, Kumar MP, Gautham A, Sriram DK, George M. Roflumilast: First approved oral selective PDE4 inhibitor for the treatment of COPD. Int. J. Heal. Clin. Res. [Internet]. 2020Sep.11 [cited 2026Feb.22];3(5):85-9. Available from: https://www.ijhcr.com/index.php/ijhcr/article/view/157